Keywords: panel, backs, cystic, fibrosis, treatment, genentech, pulmozyme

US PANEL BACKS CYSTIC FIBROSIS TREATMENT

Article | 16 August 1993

Print This

Genentech's cystic fibrosis treatment Pulmozyme (dornase alfa) has moved a step closer to the market following a recommendation for approval ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in